Nosocomial hepatitis C virus transmission from tampering with injectable anesthetic opioids
Rikita I. Hatia, Zoya Dimitrova, Pavel Skums, Elrond Yi‐Lang Teo, Chong‐Gee Teo – 22 March 2015 – The extent of provider‐to‐patient hepatitis C virus (HCV) transmission from diversion, self‐injection, and substitution (“tampering”) of anesthetic opioids is unknown. To quantify the contribution of opioid tampering to nosocomial HCV outbreaks, data from health care–related HCV outbreaks occurring in developed countries from 1990 to 2012 were collated, grouped, and compared. Tampering was associated with 17% (8 of 46) of outbreaks, but 53% (438 of 833) of cases.